Cellarity
Enhua Zhou, Ph.D., has an extensive work experience history. Enhua started as a Jere Mead Postdoctoral Fellow at Harvard T.H. Chan School of Public Health in 2006, gradually moving up to the role of Research Scientist in the Department of Environmental Health. In 2013, they transitioned to Novartis Institutes for BioMedical Research (NIBR) where they held various roles, including Investigator II and Principle Scientist I, focusing on drug discovery projects for glaucoma and presbyopia. Currently, Enhua Zhou is working at Cellarity as a Senior Scientist II and has been promoted to the role of Principal Scientist.
Enhua Zhou, Ph.D. earned a Bachelor's degree in Hydraulics and Fluid Power Technology/Technician from Wuhan University in 1999. Enhua later pursued a Master's degree in Engineering Mechanics from the same university, graduating in 2002. Enhua then attended the National University of Singapore, where they completed their Doctor of Philosophy (PhD) in Bioengineering and Biomedical Engineering in 2007.
Cellarity
1 followers
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.